Merck MRK
Merck Announces First-Quarter 2025 Financial Results
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001104659-25-038301
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.
- Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
- Pfizer PFE public float $138.0B, Jun 29, 2025
- Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025
- Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
- Regeneron Pharmaceuticals REGN public float $54.8B, Jun 30, 2025
